COVID-19 in childhood: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i12.34228Keywords:
Infection SARS-CoV-2; Children's Health; COVID-19 vaccines.Abstract
Objective: Gather scientific literature to mitigate the spread and reduce the severity of the disease. Methodology: integrative review about COVID-19 infection in pediatric patients using the keywords “COVID-19”, “SARS-CoV-2”, “Child Health” and “Vaccines”. Results: The review consists of 24 scientific articles, selected by inclusion and exclusion criteria. In addition, epidemiological data from the Brazilian Ministry of Health and 2 technical notes issued by Anvisa were used. Discussion: Mild, moderate, severe and critical symptoms were defined, explained through the pathophysiology of the disease that associates the SARS-CoV-2 virus and the renin-angiotensin system (RAS). With this, the form of transmission of this virus and diagnosis was established, which, in addition to the anamnesis and physical examination, uses laboratory tests and tomographic alterations as confirmation of the diagnostic hypothesis. Treatment is directed according to the signs and symptoms presented by the patient, in addition to supplying the body with balanced nutrition and hydration. Prevention takes place through isolation measures to avoid transmission between contacts and with the immunizing agents produced and authorized by Anvisa according to each age group. The acute and severe form that can develop in the pediatric population is the Multisystem Inflammatory Syndrome (MIS-C) causing organ dysfunction and increased inflammatory markers. The treatment of this is based on Kawasaki Disease. Conclusion: COVID-19 infection in the pediatric population can cause direct and indirect effects. Thus, further studies are needed to constantly update protocols that unify prophylactic measures and targeted treatments.
References
ANVISA. Agência Nacional de Vigilância Sanitária. Nota técnica nº 2/2022 – Vacinação de 5-11 anos, de 05 de janeiro de 2022. https://www.gov.br/saude/pt-br/coronavirus/vacinas/plano-nacional-de-operacionalizacao-da-vacina-contra-a-covid-19/notas-tecnicas/2022/nota-tecnica-02-2022-vacinacao-de-5-11-anos.pdf
ANVISA. Agência Nacional de Vigilância Sanitária. Nota técnica nº 213/2022 – CGPNI/DEIDT/SVS/MS, de 19 de julho de 2022. https://www.gov.br/saude/pt-br/coronavirus/vacinas/plano-nacional-de-operacionalizacao-da-vacina-contra-a-covid-19/notas-tecnicas/2022/nota-tecnica-213-2022-cgpni-deidt-svs-ms
Aquino, E. M., Silveira, I. H., Pescarini, J. M., Aquino, R., & Souza-Filho, J. A. D. (2020). Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciência & Saúde Coletiva, 25(suppl 1), 2423-2446.
BRASIL (2022a). Ministério da Saúde. Sistema Único de Saúde (SUS). Painel Coronavírus 2022. https://covid.saude.gov.br/
BRASIL (2022b). Ministério da Saúde. Painel Epidemiológico Nacional - Vacinômetro COVID-19. Rede Nacional de Dados de Saúde (RNDS) e Subsistema de Atenção à Saúde Indígena do SUS (SASISUS). https://infoms.saude.gov.br/extensions/DEMAS_C19_Vacina_v2/DEMAS_C19_Vacina_v2.html
BRASIL. Ministério da Saúde. Protocolo de manejo clínico da COVID-19 na Atenção Especializada. Departamento de Atenção Hospitalar, Domiciliar e de Urgência – (1ª. Ed.) ver. – Brasília: Ministério da Saúde, 2020.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise em Saúde e Doenças não Transmissíveis. Guia de vigilância epidemiológica Emergência de saúde pública de Importância nacional pela Doença pelo coronavírus 2019 – covid-19 [recurso eletrônico] – Brasília : Ministério da Saúde, 2021.
Chen, Z. M., Fu, J. F., Shu, Q., Chen, Y. H., Hua, C. Z., Li, F. B., & Zhang, Y. Y. (2020). Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World journal of pediatrics, 16(3), 240-246.
da Silva, M. C. (2022). Impactos da pandemia de COVID-19 na aprendizagem de crianças e adolescentes. Research, Society and Development, 11(5), e47611527837-e47611527837.
Deville, J. G., Song, E., Ouellette, C. P., Edwards, M. S., & Torchia, M. M. COVID-19: Clinical manifestations and diagnosis in children. Uptodate. https://www.uptodate.com/contents/covid-19-clinical-manifestations-and-diagnosis-in-children?search=covid%20treatment&topicRef=127759&source=see_link
Edwards, K. M. Orenstein, W. A., Hirsch, M. S., & Bloom, A. COVID-19: Vaccines to prevent SARS-CoV-2 infection. Uptodate. https://www.uptodate.com/contents/covid-19-vaccines-to-prevent-sars-cov-2-infection?search=covid%20vacina&source=search_result&selectedTitle=1~117&usage_type=default&display_rank=1
Ercole, F. F., Macieira, T. G. R., Wenceslau, L. C. C. Martins, A. R., Campos, C. C., & Chianca, T. C. M. (2013). Revisão integrativa: evidências na prática do cateterismo urinário intermitente/demora. Rev Latino-Am. Enfermagem, 21(1), 459-468.
Farias, E. C. F. D., Justino, M. C. A., & Mello, M. L. F. M. F. D. (2020). Síndrome inflamatória multissistêmica em criança associada à doença do coronavírus 19 na amazônia brasileira: Evolução fatal em lactente. Revista Paulista de Pediatria, 38.
Instituto da Criança e do Adolescente. Consenso Institucional para manejo da COVID-19 em crianças e adolescentes. Hospital das Clínicas – FMUSP. São Paulo, 2021. 37 p.
Kim, A., Hirsch, M. S., & Bloom, A. COVID-19: Management in hospitalizes adults. Uptodate. Disponível em: https://www.uptodate.com/contents/covid-19-management-in-hospitalized-adults?search=covid%20treatment&topicRef=127759&source=see_link Acesso em: 10 de abril de 2021.
Koh, W. C., Naing, L., Chaw, L., Rosledzana, M. A., Alikhan, M. F., Jamaludin, S. A., & Wong, J. (2020). What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PloS one, 15(10), e0240205.
Meirelles, A. F. V., Chaves, C. R. M. D. M., Pereira, C. D., Pacheco, C. A. M. S., Britto, J. A. A. D., Ramos, J. R. D. M., & Azevedo, Z. M. A. D. (2020). COVID-19 e Saúde da Criança e do Adolescente.
McIntoch, K., Hirsch, M. S., & Bloom, A. COVID-19: Epidemiology, virology, and prevention. Uptodate. https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention?sectionName=Variants%20of%20concern&search=covid%20variant%20brazil&topicRef=129849&anchor=H2895385127&source=see_link#H2895385127
Nunes, M. D. R., Pacheco, S. T. D. A., Costa, C. I. A., Silva, J. A. D., Xavier, W. D. S., & Victória, J. Z. (2020). Diagnostic tests and clinical characteristics of covid-19 in children: an integrative review. Texto & Contexto-Enfermagem, 29.
Oba, J., Carvalho, W. B. D., Silva, C. A., & Delgado, A. F. (2020). Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians. Einstein (Sao Paulo), 18.
Oliveira, W. K., et al. Como o Brasil pode deter a COVID-19. Epidemiol. Serv. Saude. Brasília, 29(2):e2020044, 2020.
Panupattanapong, S., & Brooks, E. B. (2020). New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response. Cleveland Clinic journal of medicine.
Paraluppi, V., Pintus, M. C., Fanos, V., & Marcialis, M. A. (2020). COVID-19 in newborns and in children: the state of the art. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 9(1), e090138-e090138.
Pérez-Abeledo, M., & Moreno, J. S. (2021). Variantes de SARS-CoV-2, uma historia todavía inacabada. Vacunas, 22(3), 173-179.
Rivellese, F., & Prediletto, E. (2020). ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia. Autoimmunity reviews, 19(6), 102536.
Safadi, M. A. P. (2020). The intriguing features of COVID-19 in children and its impact on the pandemic. Jornal de pediatria, 96, 265-268.
Santos, B. S. D., Santos, F. S. D., & Ribeiro, E. R. (2020). Clinical-epidemiological relation between SARS-CoV-2 and Kawasaki disease: na integrative literature. Revista Paulista de Pediatria, 30.
Sociedade Brasileira de Pediatria (SBP). Atualização sobre vacinas COVID-19 em Pediatria. Nota especial de 25 de julho de 2022. https://www.sbp.com.br/fileadmin/user_upload/23626c-NE_Atualizacao_sobre_Vacinas_COVID19_em_Pediatria.pdf.
Sociedade Brasileira de Pediatria. Vacinas COVID-19 em crianças no Brasil: Uma questão prioritária de saúde pública. Nota de alerta de 28 de Dezembro de 2021. https://www.sbp.com.br/fileadmin/user_upload/23325b-NA_Vacinas_COVID-19_em_crc_no_BR_Uma_questao_prioritaria_SaudePubl.pdf
Tortora, G. J., Case, C. L., & Funke, B. R. (2016). Microbiologia-12ª Edição. Artmed Editora.
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., & D'Antiga, L. (2020). An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. The Lancet, 395(10239), 1771-1778.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Isadora Maria de Almeida Morais; Vânia Cristina Costa de Vasconcelos Lima Carvalho; Mariana Veras Rocha Borges; Ravenna Araújo Santos; Vitória Mendes Oliveira; Lellis Henrique Costa; Victória Ellen de Almeida Morais; Guilherme Antônio Lopes de Oliveira; Carliane de Sousa Medeiros e Menezes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
